Canadian Online Pharmacy

CDER New August 20, 2014

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

August 19, 2014


New and Generic Drug Approvals

August 18, 2014

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Basaglar insulin glargine Injectable;Injection Eli Lilly and Co Tentative Approval
Cefazolin Sodium cefazolin sodium Injectable;Injection Acs Dobfar Chemistry New Strength
Dexmedetomidine Hydrochloride dexmedetomidine hydrochloride Injectable; Injection Mylan Institutional Approval
Dexmedetomidine Hydrochloride dexmedetomidine hydrochloride Injectable;Injection Par Sterile Products Approval
Docetaxel docetaxel Injectable;Injection Sandoz Manufacturing Change or Addition
Hydromorphone Hydrochloride hydromorphone hydrochloride Injectable;Injection Hospira Inc Manufacturing Change or Addition
Neurontin gabapentin Capsule;Oral Pfizer Pharms Labeling Revision
Neurontin gabapentin Tablet;Oral Pfizer Pharms Labeling Revision
Neurontin gabapentin Solution;Oral Parke Davis Labeling Revision
Rifampin rifampin Injectable;Injection Emcure Pharms Ltd Approval
Tecfidera dimethyl fumarate Capsule, Delayed Release;Oral Biogen Idec Inc Manufacturing Change or Addition

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery